REPROCELL USA Receives Maryland Stem Cell Research Fund Grant for New CDMO

October 28, 2025
REPROCELL USA has received funding from the Maryland Stem Cell Research Fund to develop a GMP-grade Contract Development and Manufacturing Organization in Maryland, expanding its stem cell manufacturing capabilities.

REPROCELL USA has received funding from the Maryland Stem Cell Research Fund (MSCRF) through the Manufacturing Assistance Grant Program, announced in a press release. The grant, part of MSCRF’s July 2025 funding cycle, supports the establishment of a Contract Development and Manufacturing Organization (CDMO) in Maryland.

The project, titled “Development of a Centralized (GMP) Contract Development and Manufacturing Organization (CDMO) and iGRP manufacturing,” will include a clean room for large-scale GMP-grade cell therapy product production. This facility will enable REPROCELL to provide two GMP technologies under one roof.

The new CDMO will expand REPROCELL’s capacity to produce working cell banks for cell therapy products, GMP-grade differentiation, gene editing services, and large-scale mesenchymal stem cells (MSC) generated from human induced pluripotent stem cells (hiPSC). The funding is structured as a 1:1 match, with REPROCELL matching the MSCRF contribution dollar for dollar.

In 2024, MSCRF also provided a grant to enhance REPROCELL’s Cytocentric Xvivo System Model 2 from BioSpherix, a closed GMP system for master cell bank manufacturing.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

10/28
Moberg Analytics Raises $600,000 to Advance Brain Monitoring Platform
10/28
Chromatin Bioscience Partners with Purespring Therapeutics on Gene Therapy Research
10/27
Region Stockholm Consolidates Hospital Imaging in Sectra Cloud System
10/27
Mumtalakat Partners with SandboxAQ to Build Bahrain’s Biotech Ecosystem
10/27
YorLabs Receives FDA Clearance for Zero-CapEx Intracardiac Imaging System

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You May Also Like